Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Katherine, Devitt"'
Autor:
Katherine Devitt, Jan Cerny, Bradley Switzer, Muthalagu Ramanathan, Rajneesh Nath, Hongbo Yu, Bruce A. Woda, Benjamin J. Chen
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 2, Pp 42-45 (2014)
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening clinical syndrome characterized by dysregulation of the immune system. Impaired function of cytotoxic T cells and natural killer cells is often seen, and T-cell malignancies represent mos
Externí odkaz:
https://doaj.org/article/38f98de583664719984dc356f3fce55b
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 2, Pp 51-53 (2014)
The optimal salvage therapy for patients with relapsed Burkitt lymphoma is unknown. Bone marrow necrosis is an underreported (2 years after the transplant. To our knowledge, this is the longest reported survival of the two syndromes in the setting of
Externí odkaz:
https://doaj.org/article/ea9e4f7c09694038a173eda99c7aa257
Publikováno v:
Journal of the Association of Genetic Technologists. 47(3)
Atypical chronic myeloid leukemia, BCR-ABL1-negative (aCML), is a rare myelodysplastic/myeloproliferative neoplasm with heterogeneous clinical and genetic features, a high rate of transformation to acute myeloid leukemia (AML), and poor survival rate
Autor:
Abigail S. Kelliher, Julianne Qualtieri, Melanie O'Donahue, Teri Oldaker, Sindhu Cherian, Maryalice Stetler-Stevenson, Lama Kdouh, Silvia T Bunting, Jonni S. Moore, Heather Harricharran, Katherine Devitt, Sara Maremont
Publikováno v:
Cytometry Part B: Clinical Cytometry. 100:282-284
Publikováno v:
Journal of the Association of Genetic Technologists. 47(2)
Acute myeloid leukemia (AML) is a group of diseases resulting from a clonal expansion of myeloid precursor cells in the bone marrow. Each subtype harbors characteristic clinical, morphologic, and molecular features. AML is most often de novo and aris
Autor:
Liam, Donnelly, Casey, Rankins, Ximena Jordan, Bruno, Wendy, McKinnon, Katherine, Devitt, Juli-Anne, Gardner
Publikováno v:
Journal of the Association of Genetic Technologists. 46(3)
Acute myeloid leukemia (AML) with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP is an uncommon subtype of AML accounting for less than 0.5% of AML cases. AML with t(8;16)/KAT6A-CREBBP has characteristic clinical and pathologic features including disseminated int
Publikováno v:
Journal of the Association of Genetic Technologists. 46(2)
Acute myeloid leukemia (AML) is caused by the arrested differentiation and dysregulated proliferation of myeloid precursors. Many AMLs harbor genetic abnormalities which determine the molecular mechanisms of the disease and are associated with distin
Publikováno v:
Journal of the Association of Genetic Technologists. 46(1)
Noonan syndrome (NS) is a relatively common autosomal dominant disorder with characteristic features and molecular alterations. The most common recurrent alteration is in the PTPN11 gene, a proto-oncogene that encodes a cytoplasmic receptor tyrosine
Publikováno v:
Journal of the Association of Genetic Technologists. 45(4)
Acute T-lymphoblastic leukemia (T-ALL) is a malignancy of immature T-cells in children and adults and although it occurs less frequently than B-ALL, it carries a worse prognosis, especially after relapse. Molecular characterization and subtyping of T
Autor:
Casey, Rankins, Jeffrey D, Covington, Katherine, Devitt, Alexandra, Kalof, Rebecca, Goetz, Juli-Anne, Gardner
Publikováno v:
Journal of the Association of Genetic Technologists. 45(3)
Pleomorphic hyalinizing angiectatic tumor (PHAT) is a rare soft tissue tumor that, despite its characteristic marked pleomorphism, is slow growing and of intermediate grade malignancy. PHAT is not known to metastasize, but is locally aggressive with